Pioneering malaria vaccine gains regulatory clearance
University of Oxford-developed R21/Matrix-M malaria vaccine has secured approval in…
University of Oxford-developed R21/Matrix-M malaria vaccine has secured approval in two African countries.
List view / Grid view
University of Oxford-developed R21/Matrix-M malaria vaccine has secured approval in…
University of Oxford-developed R21/Matrix-M malaria vaccine has secured approval in two African countries.
The UK Government is supporting the development of COVID-19 vaccines,…
The UK Government is supporting the development of COVID-19 vaccines, including two innovative UK vaccine candidates. In this article, we describe the history of these candidates and introduce innovative small and medium enterprises (SMEs) and national capabilities that are working to combat the current pandemic and improve the UK’s vaccine…